Latest filing published 27 Sept 2023 for Croda International Plc, €158k.
Filing timeline
BuySaleInsider track record
Nicholas Ian Challoner: trading record in brief
Nicholas Ian Challoner is a declared insider of Croda International PLC, with filings sourced from RNS (LSE). In total, 20 filings cover trades dated from 31 May 2013 to 26 September 2023.
The open-market record consists of 9 sales worth €5.2M, with no purchase. Besides market trades, the filings include 11 share grants. Since January 2023: no purchases and 1 sale on the market.
The newest entry dates from 27 September 2023: an open-market sale of €158k, in Croda International PLC. The median gap between a trade and its publication by RNS (LSE) is 1 day. The regulation allows three business days to notify a trade (UK MAR). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nicholas Ian Challoner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,846 shares@ £48.4548100.0% of flowXLONISIN GB00BJFFLV09RNS:4914270
- 314 shares@ £38.980.1% of flowXLONISIN GB00BJFFLV09FCA-NSM:4568165
- 10,843 shares@ £111.856227.8% of flowXLONISIN GB00BJFFLV09FCA-NSM:4305751
- 120 shares@ £0.020.0% of flowXLONISIN GB00BJFFLV09FCA-NSM:4162255
- 10,070 shares@ £65.84545.5% of flowXLONISIN GB00BJFFLV09FCA-NSM:3978639
- 1,109 shares@ £63.55570.6% of flowXLONISIN GB00BJFFLV09FCA-NSM:3928562
- 4,337 shares@ £0.020.0% of flowXLONISIN GB00BJFFLV09FCA-NSM:3914517
- 208 shares@ £0.020.0% of flowXLONISIN GB00BJFFLV09FCA-NSM:3767251
- 8,953 shares@ £51.7676.6% of flowXLONISIN GB00BJFFLV09FCA-NSM:3622036
- 2,500 shares@ £51.2518.1% of flowXLONISIN GB00BJFFLV09FCA-NSM:LSE20190503145911_14063022_20200326185143070_26352
- 12,373 shares@ £52.472414.5% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20190306100728_13992210_20200326185134385_25845
- 3,675 shares@ £47.409.3% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20180525140922_13656203_20200330111431311_4137
- 366 shares@ £0.020.0% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20180403141908_13589824_20200330111354907_24659
- 9,172 sharesXLONISIN GB00BYZWX769FCA-NSM:LSE20180308110837_13559862_20200330111427785_23239
- 3,900 shares@ £239.3457.3% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20170515171309_13226124_20200330131531018_11705
- 541 sharesN/A - Grant of a Conditional AwardISIN GB00BYZWX769FCA-NSM:LSE20161031151737_013018693_20200330143616863_23200
- 21 shares@ £20.655FCA-NSM:LSE20141002144353_012104067_20200330172032867_1586-2
- 16 shares@ £26.1838FCA-NSM:LSE20140602175504_011971904_20200330172022465_905-2
- 13 shares@ £26.942FCA-NSM:LSE20131004120103_011732189_20200330164716047-1
- 14 shares@ £24.7082FCA-NSM:LSE20130603155716_011602133_20200330164707917-2
20 of 20 declarations